Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
This study has been completed.
Study NCT00099255 Information provided by Seattle Genetics, Inc.
First Received on December 10, 2004. Last Updated on June 7, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Large Cell Lymphoma
Additional conditions recognized in this trial
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Large-Cell, Anaplastic
Lymphoma, Primary Cutaneous Anaplastic Large Cell
More general conditions related to this trial
Immune System Diseases
Lymphoma, T-Cell, Cutaneous
Neoplasms by Histologic Type
Interventions listed in this trial
Sponsors listed in this trial
Seattle Genetics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers